Science Explorer Interactive view Map
Company · Madrid · Spain

Gilead Sciences (Spain)

gilead.com/about/worldwide-operations/europe/spainROR OpenAlex
Research works
58
▼ 18% vs 2013–17
Citations
1.7k
28.4 per fractional work
Top-10% rate
12.3%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: Gilead Sciences (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.63× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.43× its world share, 1 worksImmunology and Micro…Neuroscience: 0.46× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.38× its world share, 0 worksPharmacology, Toxico…Environmental Science: 0.07× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.53× its world share, 0 worksHealth ProfessionsMedicine: 4.10× its world share, 18 worksMedicineVeterinary: 1.37× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 1.44× its world share, 1 worksEconomics, Econometr…Psychology: 0.03× its world share, 0 worksPsychologySocial Sciences: 0.07× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.4×. Every wedge is a field page.

Which keywords describe research at Gilead Sciences (Spain)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immune Response, Antiretroviral Therapy, Antiviral Therapy, Liver Disease, Epidemiology, Treatment, Genetic Variation and Hepatitis C Virus.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Immune Response5▲ 42×5 topics
  2. Epidemiology5▲ 5.8×14 topics
  3. Antiretroviral Therapy5▲ 136×5 topics
  4. Antiviral Therapy5▲ 222×3 topics
  5. Liver Disease5▲ 222×2 topics
  6. Treatment4▲ 14×4 topics
  7. Genetic Variation3▲ 70×2 topics
  8. Hepatitis C Virus3▲ 427×1 topic
  9. Ribavirin3▲ 427×1 topic
  10. HIV Infection2▲ 110×2 topics
  11. Inflammation2▲ 4.6×11 topics
  12. Hepatocellular Carcinoma2▲ 41×3 topics
  13. Mortality Rates2▲ 90×2 topics
  14. Insulin Resistance2▲ 17×2 topics
  15. Viral Load2▲ 88×2 topics
  16. HIV Transmission2▲ 92×1 topic
  17. Preexposure Prophylaxis2▲ 140×1 topic
  18. Aging1▲ 11×3 topics
  19. Drug Resistance1▲ 23×2 topics
  20. Chronic Hepatitis B1▲ 172×1 topic
  21. HIV1▲ 69×4 topics
  22. Hepatitis B Virus1▲ 172×1 topic
  23. Integrase Inhibitors1▲ 281×1 topic
  24. Nucleoside Analogues1▲ 281×1 topic
  25. Cardiovascular Disease1▲ 4.9×1 topic
  26. Metabolic Abnormalities1▲ 283×1 topic
  27. Vaccine1▲ 13×4 topics

Which research topics does Gilead Sciences (Spain) publish most on?

By volume in 2022–2025: Hepatitis C virus research, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment and Hepatitis B Virus Studies.

Hepatitis C virus research3Hepatitis C virus research: 3 fractional worksHIV/AIDS Research and In…2HIV/AIDS Research and Interventions: 2 fractional worksHIV/AIDS drug developmen…1HIV/AIDS drug development and treatment: 1 fractional worksHepatitis B Virus Studies: 1 fractional worksHIV-related health complications and treatments: 1 fractional worksLiver Disease Diagnosis …1Liver Disease Diagnosis and Treatment: 1 fractional worksHIV Research and Treatment: 1 fractional worksCAR-T cell therapy research: 1 fractional worksDiabetes Management and Education: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional works
HepatologyInfectious DiseasesEpidemiologyEmergency Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hepatitis C virus research Hepatology 3 works
  2. 2 HIV/AIDS Research and Interventions Infectious Diseases 2 works
  3. 3 HIV/AIDS drug development and treatment Infectious Diseases 1 works
  4. 4 Hepatitis B Virus Studies Epidemiology 1 works
  5. 5 HIV-related health complications and treatments Emergency Medicine 1 works
  6. 6 Liver Disease Diagnosis and Treatment Epidemiology 1 works
  7. 7 HIV Research and Treatment Virology 1 works
  8. 8 CAR-T cell therapy research Oncology 1 works
  9. 9 Diabetes Management and Education Endocrinology, Diabetes and Metabolism 0 works
  10. 10 HER2/EGFR in Cancer Research Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.4%not open53.6%

World: 28% of research is openly available.

with international co-authors62.6%domestic only37.4%

World: 19% is written across borders.

How has Gilead Sciences (Spain)'s research output changed?

Output in 2018–2022 was 18% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Madrid

All research institutions in Madrid

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.